DK1664767T3 - Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter - Google Patents
Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukterInfo
- Publication number
- DK1664767T3 DK1664767T3 DK04774922T DK04774922T DK1664767T3 DK 1664767 T3 DK1664767 T3 DK 1664767T3 DK 04774922 T DK04774922 T DK 04774922T DK 04774922 T DK04774922 T DK 04774922T DK 1664767 T3 DK1664767 T3 DK 1664767T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- biological profile
- determining
- group
- impact
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 10
- 239000000203 mixture Substances 0.000 title abstract 10
- 238000000034 method Methods 0.000 title abstract 4
- 239000003814 drug Substances 0.000 title abstract 2
- 229930014626 natural product Natural products 0.000 title 2
- 229940079593 drug Drugs 0.000 title 1
- 238000003908 quality control method Methods 0.000 title 1
- 238000000491 multivariate analysis Methods 0.000 abstract 4
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Evolutionary Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03077804A EP1512970A1 (en) | 2003-09-05 | 2003-09-05 | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| PCT/NL2004/000616 WO2005024420A1 (en) | 2003-09-05 | 2004-09-03 | Method for determining the impact of a multicomponent natural product mixture on the biological profile of a disease within a group of living systems and the development and quality control of natural product based medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1664767T3 true DK1664767T3 (da) | 2008-03-25 |
Family
ID=34130247
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774923T DK1664770T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner |
| DK04774922T DK1664767T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774923T DK1664770T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070160990A1 (da) |
| EP (3) | EP1512970A1 (da) |
| JP (2) | JP4675896B2 (da) |
| CN (2) | CN1875273A (da) |
| AT (2) | ATE378593T1 (da) |
| DE (2) | DE602004010154T2 (da) |
| DK (2) | DK1664770T3 (da) |
| EA (1) | EA011959B1 (da) |
| ES (2) | ES2297476T3 (da) |
| WO (2) | WO2005024420A1 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| EP1512970A1 (en) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| US7729789B2 (en) * | 2004-05-04 | 2010-06-01 | Fisher-Rosemount Systems, Inc. | Process plant monitoring based on multivariate statistical analysis and on-line process simulation |
| US20080183101A1 (en) * | 2006-08-17 | 2008-07-31 | Jonathan Richard Stonehouse | Salivary analysis |
| EP2135074B1 (en) * | 2007-03-30 | 2016-08-31 | Sinoveda Canada Inc | Pharmaceutical platform technology for the development of natural products |
| DE102008011013B4 (de) * | 2008-02-25 | 2014-11-13 | Mevitec Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
| KR101144237B1 (ko) * | 2009-12-29 | 2012-05-11 | 한국기초과학지원연구원 | 고분해능 질량분석법과 약리활성검사를 이용한 천연물의 약리 활성물질 발굴 방법 |
| EP2680925B1 (en) * | 2011-03-02 | 2019-11-20 | Berg LLC | Interrogatory cell-based assays and uses thereof |
| BR112014024537A2 (pt) * | 2012-04-02 | 2017-08-08 | Berg Llc | métodos para identificar moduladores de um sistema biológico, de um processo de doença, e de angiogênese |
| JP2014020831A (ja) * | 2012-07-13 | 2014-02-03 | Kyoto Univ | 混合物試料の属性を識別する方法及び装置 |
| CN105378475A (zh) * | 2013-07-01 | 2016-03-02 | 伊克斯塞拉公司 | 治疗的系统生物学方法 |
| WO2016039348A1 (ja) * | 2014-09-10 | 2016-03-17 | 一般財団法人ニッセンケン品質評価センター | タンパク質繊維の鑑別方法 |
| CA2960837A1 (en) | 2014-09-11 | 2016-03-17 | Berg Llc | Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data |
| CN109115904B (zh) * | 2018-07-25 | 2021-02-02 | 山西广誉远国药有限公司 | 一种定坤丹uplc指纹图谱的构建方法及其应用 |
| GB2606810A (en) | 2019-08-05 | 2022-11-23 | Seer Inc | Systems and methods for sample preparation, data generation, and protein corona analysis |
| CN111180007A (zh) * | 2019-12-03 | 2020-05-19 | 深圳市开物成务中医药科技有限公司 | 一种安全、有效、高质量中药开发平台系统及实现方法 |
| CN111060640A (zh) * | 2019-12-27 | 2020-04-24 | 深圳市开物成务中医药科技有限公司 | 测定与胰岛素耐受性相关的血脂谱的方法、应用及装置 |
| CN115060557B (zh) * | 2022-06-08 | 2025-01-24 | 中国农业科学院农业质量标准与检测技术研究所 | 一种基于多组学分析微生物群-肠-脑轴信号与斑马鱼神经行为关系的方法 |
| CN121171463A (zh) * | 2024-01-11 | 2025-12-19 | 生物疗法、健康生理系统共同股份公司 | 确定天然治疗性或有益产品何时通过生理作用模式发挥其治疗性或有益效果的方法 |
| CN120102266B (zh) * | 2025-05-08 | 2025-07-04 | 汉中天然谷生物科技股份有限公司 | 一种适用于植物提取物的成分检测方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
| US5563043A (en) * | 1994-10-24 | 1996-10-08 | Spiral Biotech, Inc. | Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| US6379714B1 (en) * | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| WO1997020076A1 (en) * | 1995-11-29 | 1997-06-05 | Nexstar Pharmaceuticals, Inc. | Methods for optimizing multicomponent formulations |
| JP3978529B2 (ja) * | 1998-08-03 | 2007-09-19 | 大正製薬株式会社 | 冬虫夏草の判別法 |
| US20030044846A1 (en) * | 2001-04-03 | 2003-03-06 | Gary Eldridge | Screening of chemical compounds purified from biological sources |
| WO2001066803A2 (en) * | 2000-03-09 | 2001-09-13 | Yale University | Phytomics: a genomic-based approach to herbal compositions |
| US20020095260A1 (en) * | 2000-11-28 | 2002-07-18 | Surromed, Inc. | Methods for efficiently mining broad data sets for biological markers |
| JP2005500543A (ja) * | 2001-08-13 | 2005-01-06 | ビヨンド ジェノミクス， インコーポレイテッド | 生物学的系をプロファイリングするための方法およびシステム |
| TW573125B (en) * | 2001-08-29 | 2004-01-21 | Combinatorx Inc | A screening system for identifying drug-drug interactions and methods of use thereof |
| EP1512970A1 (en) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Method for determining the impact of a multicomponent mixture on the biological profile of a disease |
| WO2006081473A2 (en) * | 2005-01-28 | 2006-08-03 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
-
2003
- 2003-09-05 EP EP03077804A patent/EP1512970A1/en not_active Withdrawn
-
2004
- 2004-09-03 DK DK04774923T patent/DK1664770T3/da active
- 2004-09-03 US US10/571,087 patent/US20070160990A1/en not_active Abandoned
- 2004-09-03 EP EP04774922A patent/EP1664767B1/en not_active Expired - Lifetime
- 2004-09-03 CN CNA2004800324024A patent/CN1875273A/zh active Pending
- 2004-09-03 WO PCT/NL2004/000616 patent/WO2005024420A1/en not_active Ceased
- 2004-09-03 ES ES04774923T patent/ES2297476T3/es not_active Expired - Lifetime
- 2004-09-03 JP JP2006525291A patent/JP4675896B2/ja not_active Expired - Fee Related
- 2004-09-03 EA EA200600539A patent/EA011959B1/ru not_active IP Right Cessation
- 2004-09-03 US US10/570,505 patent/US20070020180A1/en not_active Abandoned
- 2004-09-03 DK DK04774922T patent/DK1664767T3/da active
- 2004-09-03 CN CNA2004800325525A patent/CN1875274A/zh active Pending
- 2004-09-03 AT AT04774922T patent/ATE378593T1/de active
- 2004-09-03 JP JP2006525292A patent/JP2007508603A/ja active Pending
- 2004-09-03 DE DE602004010154T patent/DE602004010154T2/de not_active Expired - Lifetime
- 2004-09-03 ES ES04774922T patent/ES2297475T3/es not_active Expired - Lifetime
- 2004-09-03 WO PCT/NL2004/000617 patent/WO2005024421A1/en not_active Ceased
- 2004-09-03 AT AT04774923T patent/ATE378594T1/de active
- 2004-09-03 DE DE602004010155T patent/DE602004010155T2/de not_active Expired - Lifetime
- 2004-09-03 EP EP04774923A patent/EP1664770B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK1664770T3 (da) | 2008-03-25 |
| JP2007508603A (ja) | 2007-04-05 |
| US20070160990A1 (en) | 2007-07-12 |
| ES2297475T3 (es) | 2008-05-01 |
| ATE378594T1 (de) | 2007-11-15 |
| JP4675896B2 (ja) | 2011-04-27 |
| EP1664770B1 (en) | 2007-11-14 |
| EA200600539A1 (ru) | 2006-08-25 |
| EP1664767B1 (en) | 2007-11-14 |
| EA011959B1 (ru) | 2009-06-30 |
| EP1664770A1 (en) | 2006-06-07 |
| WO2005024420A1 (en) | 2005-03-17 |
| EP1512970A1 (en) | 2005-03-09 |
| DE602004010155T2 (de) | 2008-09-25 |
| DE602004010154D1 (de) | 2007-12-27 |
| US20070020180A1 (en) | 2007-01-25 |
| DE602004010155D1 (de) | 2007-12-27 |
| ES2297476T3 (es) | 2008-05-01 |
| CN1875273A (zh) | 2006-12-06 |
| JP2007510132A (ja) | 2007-04-19 |
| DE602004010154T2 (de) | 2008-09-25 |
| EP1664767A1 (en) | 2006-06-07 |
| CN1875274A (zh) | 2006-12-06 |
| WO2005024421A1 (en) | 2005-03-17 |
| ATE378593T1 (de) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200600539A1 (ru) | Способ определения воздействия многокомпонентной смеси естественных продуктов на биологический профиль заболевания в пределах группы живых систем и разработка и контроль качества лекарственных препаратов на основе естественных продуктов | |
| ATE463294T1 (de) | Verfahren zur konzentration und reinigung von biologischen verbindungen | |
| CY1120670T1 (el) | Μονοκλωνικα αντισωματα εναντι του αναστολεα μονοπατιου ιστικου παραγοντα (tfpi) | |
| CY1111612T1 (el) | Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her | |
| ATE533358T1 (de) | Verfahren zum kontrollieren von schädlingen mittels rnai | |
| EA030259B8 (ru) | Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf | |
| ATE490984T1 (de) | Methode zur produktion und evaluierung der zytotoxizität von kir2dl nk-rezeptor antikörpern | |
| CY1114701T1 (el) | Συνθεσεις και μεθοδοι για αυξηση ασβεστοποιησης οστων | |
| ATE488251T1 (de) | Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen | |
| BRPI0411743A (pt) | método e composições para tratar doenças relacionadas a amilóides | |
| EA200501676A1 (ru) | Фосфонатсодержащие ингибиторы киназы (варианты), способ их получения, фармацевтическая композиция, лекарственная форма на их основе и способ ингибирования киназы у млекопитающего (варианты) | |
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| EA200802167A1 (ru) | Лекарства и применения | |
| ATE392430T1 (de) | Verfahren zur herstellung von dipeptiden | |
| UA94206C2 (ru) | Бактериальные факторы вирулентности и варианты их применения | |
| DK1694354T3 (da) | Fremgangsmåde til at forhindre og behandle diabetes ved anvendelse af neurturin | |
| DE602005026931D1 (de) | Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik | |
| ATE481101T1 (de) | Verfahren zur behandlung von angstzuständen | |
| BRPI0401771A (pt) | Processo e dispositivo para a determinação da composição de isÈmeros em processos de preparação de isocianato | |
| ATE323539T1 (de) | Chromatographie-verfahren und vorrichtung welche einen konzentrations-schritt integrieren | |
| NO20064136L (no) | Anti-epcam-immunglobuliner | |
| ATE463476T1 (de) | Verfahren zur herstellung von acrysäure und polymerisierbare verbindungen | |
| BRPI0615691A8 (pt) | Método para a preparação de 6-((3s,4r)-4-(4-amino-5-cloro-2-metoxibenzamido)-3-metoxipiperidin-1-il) hexanoato de (r)-quinuclidin-3-ila ou sal do mesmo | |
| ATE432997T1 (de) | Therapieüberwachung für tumoren unter benutzung acc133 mrna | |
| DE602006009901D1 (de) | Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin |